Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies
- PMID: 18404493
- PMCID: PMC2096648
- DOI: 10.1007/s11302-006-9012-4
Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies
Abstract
Adenosine A(2B) receptors of native human and rodent cell lines were investigated using [(3)H]PSB-298 [(8-{4-[2-(2-hydroxyethylamino)-2-oxoethoxy]phenyl}-1-propylxanthine] in radioligand binding studies. [(3)H]PSB-298 showed saturable and reversible binding. It exhibited a K(D) value of 60 +/- 1 nM and limited capacity (B(max) = 3.511 fmol per milligram protein) at recombinant human adenosine A(2B) receptors expressed in human embryonic kidney cells (HEK-293). The addition of sodium chloride (100 mM) led to a threefold increase in the number of binding sites recognized by the radioligand. The curve of the agonist 5'-N-ethylcarboxamidoadenosine (NECA) was shifted to the right in the presence of NaCl, while the curve of the antagonist PSB-298 was shifted to the left, indicating that PSB-298 may be an inverse agonist at A(2B) receptors. Adenosine A(2B) receptors were shown to be the major adenosine A(2) receptor subtype on the mouse neuroblastoma x rat glioma hybrid cell line NG108-15 cells. Binding studies at rat INS-1 cells (insulin secreting cell line) demonstrated that [(3)H]PSB-298 is a selective radioligand for adenosine A(2B) binding sites in this cell line.
Figures












References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2174/1568026033392264', 'is_inner': False, 'url': 'https://doi.org/10.2174/1568026033392264'}, {'type': 'PubMed', 'value': '12570760', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12570760/'}]}
- Volpini R, Costanzi S, Vittori S et al (2003) Medicinal chemistry and pharmacology of A2B adenosine receptors. Curr Top Med Chem 3:427–33 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/sj.bjp.0706272', 'is_inner': False, 'url': 'https://doi.org/10.1038/sj.bjp.0706272'}, {'type': 'PMC', 'value': 'PMC1576223', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1576223/'}, {'type': 'PubMed', 'value': '15980878', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15980878/'}]}
- Holgate ST (2005) The identification of the adenosine A2B receptor as a novel therapeutic target in asthma. Br J Pharmacol 145:1009–015 - PMC - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1124/jpet.103.056036', 'is_inner': False, 'url': 'https://doi.org/10.1124/jpet.103.056036'}, {'type': 'PubMed', 'value': '14563788', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14563788/'}]}
- Abo-Salem OM, Hayallah AM, Bilkei-Gorzo A et al (2004) Antinociceptive effects of novel A2B adenosine receptor antagonists. J Pharmacol Exp Ther 308:358–66 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0165-6147(98)01179-1', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0165-6147(98)01179-1'}, {'type': 'PubMed', 'value': '9612090', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9612090/'}]}
- Feoktistov I, Polosa R, Holgate ST et al (1998) Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 19:148–53 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1021/jm990499b', 'is_inner': False, 'url': 'https://doi.org/10.1021/jm990499b'}, {'type': 'PubMed', 'value': '11170626', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11170626/'}]}
- Harada H, Asano O, Hoshino Y et al (2001) 2-Alkynyl-8-aryl-9-methyladenosines as novel adenosine receptor antagonists: their synthesis and structure–activity relationship toward hepatic glucose production induced via agonism of the A2B receptor. J Med Chem 44:170–79 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous